Tumor-infiltrating dendritic cells are defective in their antigen- presenting function and inducible B7 expression in rats

International Journal of Cancer

Volumn 72, Issue 4, 1997, Pages 619-624

  Chaux, Pascal ^a   Favre, Nathalie ^a   Martin, Monique ^a   Martin, François ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CANCER IMMUNOLOGY; COLON CARCINOMA; DENDRITIC CELL; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ADENOCARCINOMA; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; COLONIC NEOPLASMS; DENDRITIC CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; RATS; RATS, INBRED F344; RATS, WISTAR; T-LYMPHOCYTES;

EID: 0030786569     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970807)72:4<619::AID-IJC12>3.0.CO;2-6     Document Type: Article

References (20)

1. BOON, T., CEROTTINI, J.C., VAN DEN EYNDE, B., VAN DER BRUGGEN, P. and VAN PEL, A., Tumor rejection antigens recognized by T lymphocytes. Ann. Rev. Immunol., 12, 337-365 (1994).
2. BOUSSIOTIS, V.A., FREEMAN, G.F., GRIBBEN, J.G. and NADLER, L.M., The role of B7-1/B7-2:CD28/CTLA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response. Immunol. Rev., 153, 5-26 (1996).
3. CAIGNARD, A., MARTIN, M.S., MICHEL, M.F. and MARTIN, F., Interaction between two cellular subpopulations of a rat colonic carcinoma when inoculated to the syngeneic host. Int. J. Cancer, 36, 273-279 (1985).
4. CAIGNARD, A., PELLETIER, H. and MARTIN, F., Specificity of the immune response leading to protection or enhancement by regressive and progressive variants of a rat colon carcinoma. Int. J. Cancer, 42, 883-886 (1988).
5. CAUX, C., MASSACRIER, C. VANBERVLIET, B., DUBOIS, B., VAN KOOTEN, C., DURAND, I. and BANCHEREAU, J., Activation of human dendritic cells through CD40 cross-linking. J. exp. Med., 180, 1263-1272 (1994).
6. CHANG, C.H., FURUE, M. and TAMAKI, K., B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-γ or by interleukin-10. Europ. J. Immunol., 25, 394-398 (1995).
7. CHAUX, P., HAMMANN, A., MARTIN, F. and MARTIN, M., Surface phenotype and functions of tumor-infiltrating dendritic cells: CD8 expression by a cell subpopulation. Europ. J. Immunol., 23, 2517-2525 (1993).
8. CHAUX, P., MOUTET, M., FAIVRE, J., MARTIN, F. and MARTIN, M., Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 co-stimulatory molecules of the T cell activation. Lab. Invest., 74, 975-983 (1996).
9. DENFELD, R.W., DIETRICH, A., WUTTIG, C., TANCZOS, E., WEISS, J.M., VANSCHEIDT, W., SCHÖPF, E. and SIMON, J.C., In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity. Int. J. Cancer, 62, 259-265 (1995).
10. GABRILOVITCH, D.I., CHEN, H.L., GIRGIS, K.R., CUNNINGHAM, H.T., MENY, G.M., NADAF, S., KAVANAUGH, D. and CARBONE, D.P., Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature (Med.), 2, 1096-1103 (1996).
11. + T cells is dependent on B7 (CD80), augmented by CD58, but relatively uninfluenced by CD54 expression. Int. Immunol., 7, 1505-1513 (1995).
12. HUANG, A.Y.C., BRUCH, A.T., PARDOLL, D.M. and LEVITSKY, H.I., Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo? J. exp. Med., 183, 769-776 (1996).
13. INABA, K. and 12 OTHERS, The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. exp. Med., 180, 1849-1860 (1994).
14. LARSEN, C.P., RITCHIE, S.C., HENDRIX, R., LINSLEY, P.S., HATHCOCK, K.S., MODES, R.J., LOWRY, R.P. and PEARSON, T.C., Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol., 152, 5208-5219 (1994).
15. LINSLEY, P.S., BRADY, W., URNES, M., GROSMAIRE, L.S., DAMLE, N.K. and LEDBETTER, J.A., CTLA4 is a second receptor for the B cell activation antigen B7. J. exp. Med., 174, 561-569 (1991).
16. NESTLE, P.O., BURG, G., FÄH, J., WRONE-SMITH, T. and NICKOLOFF, B.J., Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. Amer. J. Pathol., 150, 641-651 (1997).
17. RADVANYI, L.G., SHI, Y., VAZIRI, H., SHARMA, A., DHALA, R., MILLS, G.B. and MILLER, R.G., CD28 co-stimulation inhibits TCR-induced apoptosis during a primary T cell response. J Immunol., 156, 1788-1798 (1996).
18. SALLUSTO, F. and LANZAVECCHIA, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor-a. J. exp. Med., 179, 1109-1118 (1994).
19. STEINMAN, R.M., The dendritic cell system and its role in immunogenicity. Ann. Rev. Immunol., 9, 271-296 (1991).
20. STEPTOE, R.J. and THOMSON, A.W., Dendritic cells and tolerance induction. Clin. exp. Immunol., 105, 397-402 (1996).